Source: PLOS ONE. Unidade: FMRP
Subjects: PROTEÍNAS QUINASES (GENÉTICA), PROTEÍNAS PROTO-ONCOGÊNICAS (GENÉTICA), EXPRESSÃO GÊNICA, OSTEOSSARCOMA
ABNT
MARTIN, Jeffrey W et al. Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma. PLOS ONE, v. 9, n. 5, p. e95843-1 - e95843-8, 2014Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0095843. Acesso em: 21 maio 2024.APA
Martin, J. W., Chilton-MacNeill, S., Koti, M., Wijnen, A. J. van, Squire, J. A., & Zielenska, M. (2014). Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma. PLOS ONE, 9( 5), e95843-1 - e95843-8. doi:10.1371/journal.pone.0095843NLM
Martin JW, Chilton-MacNeill S, Koti M, Wijnen AJ van, Squire JA, Zielenska M. Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma [Internet]. PLOS ONE. 2014 ; 9( 5): e95843-1 - e95843-8.[citado 2024 maio 21 ] Available from: https://doi.org/10.1371/journal.pone.0095843Vancouver
Martin JW, Chilton-MacNeill S, Koti M, Wijnen AJ van, Squire JA, Zielenska M. Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma [Internet]. PLOS ONE. 2014 ; 9( 5): e95843-1 - e95843-8.[citado 2024 maio 21 ] Available from: https://doi.org/10.1371/journal.pone.0095843